What is the step‑by‑step management of a patient presenting to the office requesting a medical abortion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Step-by-Step Management of Medical Abortion Request

Provide same-day assessment and initiate medical abortion within one week, using mifepristone 200 mg orally followed by misoprostol 800 mcg buccally 24-48 hours later for pregnancies up to 63 days (9 weeks) from last menstrual period. 1, 2

Initial Assessment (Ideally Within 1 Week of Request)

Confirm Pregnancy and Gestational Age

  • Obtain last menstrual period (LMP) and calculate gestational age from first day of LMP 3, 4
  • Perform transvaginal or abdominal ultrasound to confirm intrauterine pregnancy and gestational age 3, 5
  • If gestational sac not visible on ultrasound with LMP ≤42 days: Consider pregnancy of unknown location—you can either initiate same-day medication abortion while simultaneously ruling out ectopic with serial hCG testing, or delay treatment until diagnosis is established with repeat ultrasound 6
  • If gestational age 64-70 days: Medical abortion remains highly effective (92.3% success rate) 7
  • If gestational age 71-77 days: Efficacy drops to 86.7% with significantly higher ongoing pregnancy rates (8.7%); surgical abortion may be preferable, though medical abortion can still be offered if strongly preferred 7

Eligibility Screening

  • Confirm patient desires abortion and is making an informed, voluntary decision 3
  • Rule out ectopic pregnancy via ultrasound or serial hCG if pregnancy of unknown location 6
  • Assess for contraindications to mifepristone/misoprostol (chronic adrenal failure, hemorrhagic disorders, anticoagulation therapy, inherited porphyrias) 3
  • Do not require mandatory counseling or mandatory waiting periods—these create barriers without improving safety 1

Counseling on What to Expect

  • Explain the regimen: mifepristone in office, then misoprostol at home 24-48 hours later 2
  • Discuss expected bleeding and cramping—heavier than normal menses with passage of tissue 4
  • Explain efficacy: 97.7% overall success, highest at 29-42 days (98.8%), lowest at 57-63 days (95.5%) 2
  • Discuss rare complications: infection requiring hospitalization (0.01%), transfusion (0.03%) 2
  • Provide pain management plan: NSAIDs as first-line, with opioid analgesics if needed 4

Treatment Initiation (Within 1 Week of Assessment)

Medication Administration

  • Administer mifepristone 200 mg orally in office 2
  • Provide misoprostol 800 mcg for buccal administration at home 24-48 hours later 2
  • Instruct patient to place 4 tablets (200 mcg each) between cheek and gum for 30 minutes, then swallow remaining fragments 2

Consider Alternative Service Delivery

  • Offer assessment by phone or video call if patient prefers 1
  • Allow self-referral without requiring GP referral 1
  • Maximize role of nurses and midwives in providing care 1

Follow-Up (1 Week After Misoprostol)

Confirm Abortion Success

  • Offer patient choice of follow-up method: in-clinic ultrasound, remote assessment with serum hCG, or self-assessment with urine pregnancy test 8
  • Remote/self-assessment is equally effective and safe as in-clinic follow-up, with higher patient satisfaction 8
  • If using urine pregnancy test remotely, multilevel tests result in fewer unscheduled visits than high-sensitivity tests 8
  • Serum hCG measurement is acceptable when ultrasound unavailable, though ultrasound remains gold standard 4

Management of Incomplete Abortion

  • If ongoing pregnancy detected: Offer uterine aspiration or repeat misoprostol dose 3
  • Aspiration needed in 2.3% overall, increasing with gestational age 2
  • Ongoing pregnancy rates: 3.6% at 64-70 days, 8.7% at 71-77 days 7

Critical Pitfalls to Avoid

  • Do not delay care with unnecessary barriers: Multiple visits, mandatory waiting periods, and compulsory counseling increase complications without improving safety 1
  • Do not restrict to FDA-approved regimen: The evidence-based regimen (200 mg mifepristone + 800 mcg buccal misoprostol) is safer and more effective than the outdated FDA protocol 2
  • Do not allow personal beliefs to delay referral: If unwilling to provide abortion care, immediately refer to appropriate provider 1, 9
  • Do not require in-person follow-up: Remote assessment is equally safe and preferred by most patients 8
  • Ensure timely referral if beyond your gestational age capacity: Some services cannot provide abortion at later gestational ages; avoid making patients repeat assessments 1

References

Related Questions

What is the definition of abortion according to the Mexican clinical practice guidelines?
What should I do if I haven't had my period yet, a month after a medical abortion?
When should I seek medical attention after attempting an abortion at home using mifepristone (anti-progestin) and misoprostol (prostaglandin E1 analogue)?
What is the recommended medical abortion regimen, including medication types, doses, routes of administration, timing, follow‑up, and contraindications, for a woman with an intra‑uterine pregnancy of ≤9 weeks gestation in India?
What is the approach to abortion counseling in an Objective Structured Clinical Examination (OSCE)?
How should a post‑viral neck rash be evaluated and managed?
What milrinone infusion rate (mL per hour) is required to achieve a dose of 0.25 µg per kilogram per hour for a patient weighing 108.9 kg?
Is daily oral Truvada (tenofovir disoproxil fumarate + emtricitabine) safe for HIV pre‑exposure prophylaxis (PrEP) while breastfeeding, and should Apretude (cabotegravir) be avoided during lactation?
What treatment would you recommend to improve glycemic control in a 62-year-old patient with poorly controlled type 2 diabetes mellitus and no major comorbidities?
What is the most likely cause of anemia in a 78‑year‑old patient with mild normocytic/macrocytic anemia, low MCHC, high RDW, low transferrin, elevated CRP, and normal vitamin B12, folate, and ferritin, and what is the appropriate management?
What are the likely diagnoses and recommended work‑up and treatment for a patient with a one‑month history of progressively worsening right posterior oropharyngeal pain radiating to the ear, pain on swallowing, new right facial pressure and headache, a history of sinusitis, and negative rapid streptococcal test and neck ultrasound?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.